| 07/03/2017 |
FSMA_Opinion_2017_01 |
The notion of leverage in the context of the AIF Law |
| 28/11/2017 |
FSMA_Opinion_2017_03 |
Communication on the application of the technical FAQs 5 and 34 on the moratorium |
| 14/05/2019 |
FSMA_Opinion_2019_02 |
FSMA opinion on the standstill period provided for in the Royal Decree on Takeover Bids |
| 22/10/2019 |
FSMA_Opinion_2019_04 |
Mention of the target market in prospectuses of issuers not subject to MiFID II |
| 21/10/2020 |
FSMA_Opinion_2020_02 |
Considerations and good practices with respect to inside information disclosures by listed biotech companies |
| 08/12/2020 |
FSMA_Opinion_2020_04 |
Transfer of vested reserves to the pension institution of a new employer |
| 21/06/2021 |
FSMA_Opinion_2021_04 |
Minimum standards governing the structure of SPACs, the disclosure of information about SPAC shares and trading in those shares on Euronext Brussels |
